Letter to the Editor: “Intralesional injection of mitomycin C following visual internal urethrotomy for recurrent urethral stricture: A randomized controlled study”
Restricted accessLetterFirst published online February, 2026
Letter to the Editor: “Intralesional injection of mitomycin C following visual internal urethrotomy for recurrent urethral stricture: A randomized controlled study”
MostafaDHigazyARaslanML, et alIntralesional injection of mitomycin C following visual internal urethrotomy for recurrent urethral stricture: a randomized controlled study. Urologia2025; 92(2): 288–293.
2.
HughesMBlakelySNikolavskyD.Advancements in transurethral management of urethral stricture disease. Curr Opin Urol2021; 31(5): 504–510.
3.
Shams-ul-IslamBWAAli ShahidMAAnsariI, et alRole of mitomycin C in anterior urethral stricture recurrence after internal urethrotomy. Pak J Med Health Sci2019; 13(2): 497–499.
4.
RatanSKSharmaNKSaxenaG, et alCystoscopic local application of mitomycin-C following internal urethrotomy for recurrent short urethral strictures in children: a preliminary experience. J Indian Assoc Pediatr Surg2025; 30(4): 452–458.
5.
PranataFHHidayatullahFKlopingYP, et alThe efficacy and safety of mitomycin C intra urethral injection to prevent recurrent urethral stricture: a systematic review and meta-analysis. Ann Med Surg (Lond)2022; 77: 103576.
